Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 558-563

  Rotimi, Charles ^a   Puras, Angel ^a   Cooper, Richard ^a   McFarlane Anderson, Norma ^b   Forrester, Terrence ^b   Ogunbiyi, Olufemi ^c   Morrison, Linda ^d   Ward, Ryk ^d  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin converting enzyme; angiotensinogen; blacks; genetics; hypertension, genetic

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

CONFERENCE PAPER; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; JAMAICA; MAJOR CLINICAL STUDY; NEGRO; NIGERIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029917006     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.558     Document Type: Conference Paper

References (49)

1. Cooper RS, Rotimi CN. Hypertension in populations of West African origin: is there a genetic predisposition? J Hypertens. 1994; 12:215-227.
2. Ogunlesi A, Osotimehin B, Abbiyessuku F, Kadiri S, Akinkugbe O, Liao Y, Cooper R. Blood pressure and educational level among factory workers in Ibadan, Nigeria. J Hum Hypertens. 1991;5: 375-380.
3. Foster C, Rotimi C, Fraser H, Sundarum C, Liao Y, Gibson E, Holder Y, Hoyos M, Mellanson-King R. Hypertension, diabetes and obesity in Barbados: findings from a recent population-based survey. Ethn Dis. 1993;3:404-412.
4. Akinkubge OO. World epidemiology of hypertension in blacks. In: Hall WD, Saunders E, Shulman NB, eds. Hypertension in Blacks. Chicago, Ill: Year Book Medical Publishers Inc; 1985:3-16.
5. MacGregor GA, Markandu ND, Rouiston JE, Jones JC, Morton JJ. Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature. 1981;291:329-331.
6. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation. 1988;77(6 pt 2):I4-I13.
7. Dzau VJ, Burt DW, Pratt RE. Molecular biology of the renin-angiotensin system. Am J Physiol. 1988;255:563-573.
8. Walker WG, Whelton PK, Saito H, Russel RP, Hermann J. Relationship between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1979;1:287-291.
9. Fasola AF, Martz BL, Helmer OM. Plasma renin activity during supine exercise in offspring of hypertensive parents. J Appl Physiol. 1968;25:410-415.
10. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RP, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
11. Hata A, Namikawa C, Sasaki M, Sato K, Nalamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994;93:1285-1287.
12. Caulfield M, Lavender P, Newell-Price J, Farrall M, Daniel H, Kamdar S, Lawson M, Fogarty P, Clark AJL. Linkage of the angiotensinogen gene to human essential hypertension in African Caribbeans. N Engl J Med. 1994;330:1629-1633.
13. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation. 1994;90:2207-2212.
14. 235, the variant of angiotensinogen gene, in severe, familial hypertension. Biochem Biophys Res Commun. 1993;197:833-839.
15. Tiret L, Rigat B, Viskivis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence from combined segregation and linkage analysis that a variant of the angiotensin converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51: 197-205.
16. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994;90:2199-2202.
17. Forrester T, Cooper R, Bennet F, McFarlane-Anderson N, Puras A, Rotimi C, Durazo R, Tewksbury D, Ward R. Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens. In press.
18. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
19. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perry MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic cardiomyopathy. Lancet. 1993;342:1065-1066.
20. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
21. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou J, Arveiler D, Luc G, Amouyel P, Cambien F. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993;341:991-992.
22. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
23. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GAJ. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
24. Mattu R, Needham E, Galton D, Frangos E, Clark A, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation. 1995;91:270-274.
25. Zee RYL, Lou Y, Griffiths LF, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme (ACE) gene with essential hypertension. Biochem Biophys Res Commun. 1992;184: 9-15.
26. Lee E. Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol. 1994;37:212-214.
27. Ishigami T, Iwamoto T, Tamura K, Yamaguchi S, Iwasawa K, Uchino K, Umemura S, Ishii M. Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: ethnic difference of ACE genotype. Am J Hypertens. 1995;8:95-97.
28. Higashimori K, Zhao Y, Higaki J, Kamitanii A, Katsuya T, Nakura J, Miki T, Mikami H, Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun. 1993;191:399-404.
29. Rutledge D, Browe C, Kubilis P, Ross E. Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am J Hypertens. 1994;7:651-654.
30. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CFW, Watt GCM. The angiotensin I-converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21:455-460.
31. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992;1:72-75.
32. Barley J, Blackwood A, Carter N, Crews D, Cruickshank K, Jeffery S, Ogulesi A, Sagnella G. Angiotensin converting enzyme insertion/ deletion polymorphism: association with ethnic origin. J Hypertens. 1994;12:955-957.
33. Duru K, Farrow S, Wang J, Locketteb W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens. 1994;7:759-762.
34. Kamdar S, Daniel H, Fogarty P, Lawson M, Munroc P, Caulfield M. ACE insertion/deletion polymorphism in Vincentian African Caribbeans with essential hypertension. J Hum Hypertens. 1994; 8:611. Abstract.
35. Schmidt S, Van Hooft IMS, Grobbee DE, Ganten D, Eberhard R. Polymorphism of the angiotensin I-converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens. 1993;11:345-348.
36. Berge KE, Berg K. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet. 1994;45:169-174.
37. Gu X, Spaepen M, Guo C, Fagard R, Amcry A, Lijnen P, Cassiman JJ. Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population. J Hum Hypertens. 1994;8:683-685.
38. Ataman S, Cooper R, Rotimi C, Osotimehin B, Muna W, Kingue S, Fraser H, McGee D. Standardization of blood pressure in an international collaborative study. J Clin Epidemiol. In press.
39. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP 1 dipeptidyl carboxypeptidase). Nucleic Acids Res. 1992;20:1433.
40. Ludwig E, Corneli PS, Anderson JL, Marshal HW, Lalouel J-M, Ward RH. Coronary stenosis precedes increased genetic risk of myocardial infarction associated with the angiotensin-converting enzyme gene. Circulation. 1995;91:2120-2124.
41. Shanmugan V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl. 1993;3:120-121.
42. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, Osotimehin B, Ward R. Angiotensinogen gene in human hypertension: lack of an association of the 235T allele among African Americans. Hypertension. 1994;24:591-594.
43. Rotimi CN, Cooper RS, Ataman SL, McGee D, Osotimehin B, Kadiri S, Muna W, Kingue S, Fraser H, Cruickshank K. Distribution of anthropometric variables and the prevalence of obesity in populations of West African origin: the International Collaborative Study on Hypertension in Blacks. Obesity Res. 1995;3(suppl 2): 95S-106S.
44. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
45. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Roulea J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992; 327:669-677.
46. Adams JP, Ward RH. Admixture studies and the detection of selection. Science. 1973;180:1137-1143.
47. Chakraborty R, Kamboh MI, Nwanko M, Ferrell RE. Caucasian genes in American blacks: new data. Am J Hum Genet. 1992;50: 145-155.
48. Cooper RS, Rotimi CN. Establishing the epidemiologic basis for prevention of cardiovascular diseases in Africa. Ethn Dis. 1993;3: S13-S23.
49. Ward RH. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press Publishers; 1990:83-102.